Literature DB >> 23442361

Long-term results of extracorporeal shockwave therapy and core decompression in osteonecrosis of the femoral head with eight- to nine-year follow-up.

Ching-Jen Wang1, Chung-Cheng Huang, Jun-Wen Wang, To Wong, Ya-Ju Yang.   

Abstract

BACKGROUND: This study analyzed the long-term outcomes of extracorporeal shockwave therapy (ESWT) and core decompression for early osteonecrosis of the femoral head (ONFH) with 8- to 9-year follow-up.
METHODS: The study cohort consisted of 48 patients with 57 hips including 23 patients with 29 hips in the ESWT group and 25 patients with 28 hips in the surgical group. Patients in ESWT group received shockwave therapy to the affected hip. Patients in surgical group underwent core decompression and autogenous cancellous bone and allogenous fibular graft. The average length of follow-up was 103.5 ± 3.4 (ranged 93-106) months and 104.5 ± 4.3 (ranged 95-108) months for the ESWT and the surgical group, respectively. The evaluations included clinical assessment for pain and function, X-ray and MRI of the affected hips.
RESULTS: The overall clinical results were 76% good or fair and 24% poor for the ESWT group; and 21% good or fair and 79% poor for the surgical group. THA was performed in 3% and 21% at one year, 10% and 32% at 2 years and 24% and 64% at 8-9 years for ESWT and the surgical group respectively. Significant differences in pain and Harris hip scores were observed at different time intervals favoring the ESWT group. There was a trend of decrease in the size of the lesion in the ESWT group when compared with the surgical group.
CONCLUSION: ESWT appears to be more effective than core decompression and bone grafting for early ONFH with 8- to 9-year long-term follow-up.

Entities:  

Mesh:

Year:  2012        PMID: 23442361     DOI: 10.4103/2319-4170.104413

Source DB:  PubMed          Journal:  Biomed J        ISSN: 2319-4170            Impact factor:   4.910


  21 in total

1.  A current review of non-vascularized bone grafting in osteonecrosis of the femoral head.

Authors:  Todd P Pierce; Randa K Elmallah; Julio J Jauregui; Shiva Poola; Michael A Mont; Ronald E Delanois
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

Review 2.  The use of non-vascularized bone grafts to treat osteonecrosis of the femoral head: indications, techniques, and outcomes.

Authors:  Assem A Sultan; Anton Khlopas; Peter Surace; Linsen T Samuel; Mhamd Faour; Nipun Sodhi; Viktor E Krebs; Kim L Stearns; Robert M Molloy; Michael A Mont
Journal:  Int Orthop       Date:  2018-07-23       Impact factor: 3.075

3.  Long-term outcomes of Phemister bone grafting for patients with non-traumatic osteonecrosis of the femoral head.

Authors:  Cheng-Ta Wu; Shih-Hsiang Yen; Po-Chun Lin; Jun-Wen Wang
Journal:  Int Orthop       Date:  2018-06-18       Impact factor: 3.075

Review 4.  Treatment of bone marrow lesions (bone marrow edema).

Authors:  Erik F Eriksen
Journal:  Bonekey Rep       Date:  2015-11-25

5.  Core decompression versus other joint preserving treatments for osteonecrosis of the femoral head: a meta-analysis.

Authors:  Francesco Sadile; Alessio Bernasconi; Sergio Russo; Nicola Maffulli
Journal:  Br Med Bull       Date:  2016-06       Impact factor: 4.291

Review 6.  Treatment of osteonecrosis in systemic lupus erythematosus: a review.

Authors:  T Andrew Ehmke; Jeffrey J Cherian; Eddie S Wu; Julio J Jauregui; Samik Banerjee; Michael A Mont
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

7.  Effect of Osteonecrosis Intervention Rod Versus Core Decompression Using Multiple Small Drill Holes on Early Stages of Necrosis of the Femoral Head: A Prospective Study on a Series of 60 Patients with a Minimum 1-Year-Follow-Up.

Authors:  Haixiong Miao; Dongping Ye; Weiguo Liang; Yicun Yao
Journal:  Open Orthop J       Date:  2015-05-15

8.  Management of femoral head osteonecrosis: Current concepts.

Authors:  Sujit Kumar Tripathy; Tarun Goyal; Ramesh Kumar Sen
Journal:  Indian J Orthop       Date:  2015 Jan-Feb       Impact factor: 1.251

9.  Effectiveness of Lower Energy Density Extracorporeal Shock Wave Therapy in the Early Stage of Avascular Necrosis of the Femoral Head.

Authors:  Yong Han; June-Kyung Lee; Bong-Yeon Lee; Hoi-Sung Kee; Kwang-Ik Jung; Seo-Ra Yoon
Journal:  Ann Rehabil Med       Date:  2016-10-31

10.  Extracorporeal Shockwave Therapy Modulates the Expressions of Proinflammatory Cytokines IL33 and IL17A, and Their Receptors ST2 and IL17RA, within the Articular Cartilage in Early Avascular Necrosis of the Femoral Head in a Rat Model.

Authors:  Jai-Hong Cheng; Shun-Wun Jhan; Chieh-Cheng Hsu; Hung-Wen Chiu; Shan-Ling Hsu
Journal:  Mediators Inflamm       Date:  2021-07-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.